Bellevue Group AG

Q1 2022 13F Holdings Report, Stock Holdings

Signature - Title
Christoph Eisenring / Stefano Montalbano - Head Legal & Compliance / CFO
Location
Kuesnacht, Switzerland
Holdings as of
March 31, 2022
Value $
$8.61B
Num holdings
177
Date filed
5/13/2022, 04:19 PM
Description
All US holdings of this investor are reported in this report.
Previous filing
Q4 2021 - Feb 10, 2022
Next filing
Q2 2022 - Aug 11, 2022
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q1 compared to 2021 Q4 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Christoph Eisenring / Michael Hutter Head Legal & Compliance / CFO Kuesnacht, Switzerland 5/11/2022

Other Included Managers (3):

Num Name File Number
1 BB Biotech AG 028-06964
2 Bellevue Asset Management AG 028-16892
3 Bellevue Asset Management (UK) Ltd. 028-20408